Hologic Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
All right. Good morning, everyone. We're back. I'm Amit Hazan, the medical technology analyst at Goldman Sachs. From my team, Jamie and Phil are probably on in the background as well. And we're excited to have as our next presenter, Hologic, a company we actually don't cover, but I used to back in the day. And so we've got Steve MacMillan, the Chairman, President and Chief Executive Officer, with us this morning; and Mike Watts might chime in as well, Vice President, Investor Relations. And so first and foremost, these are busy times for you guys, Steve. So I must say thank you so much for joining us, and welcome.
Well, thank you, Amit. Good to see you again after all these years.
Yes. Likewise. My history with Hologic goes back a long way. It was a small-cap stock and Cytyc and Gen-Probe are all names I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |